Posted On: 04/22/2014 9:58:01 AM
Post# of 74549
$ADXS Headlines
UPDATE: Advaxis Reports Japanese Patent Officer Has Granted Notice of Allowance for Two Patent Apps Covering Cancer Immunotherapy Platform Technology
6:39 a.m. April 14, 2014
- benzinga.com
UPDATE: Advaxis Receives Notice of Allowance From U.S. Patent and Trademark Office for Three Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy Platform Technology
6:33 a.m. April 1, 2014
- benzinga.com
Advaxis Announces Closing of Public Offering of Common Stock, Collects $14.07M in Gross Proceeds
3:32 p.m. March 31, 2014
- benzinga.com
But we really believe our stock is worth $4
7:19 a.m. March 27, 2014
- Seeking Alpha
UPDATE: Advaxis Announces Proposed Public Offering of Common Stock
3:10 p.m. March 26, 2014
- benzinga.com
Advaxis Receives Patent in Japan for ADXS-HPV for the Treatment of Cervical Cancer
6:31 a.m. March 18, 2014
- benzinga.com
Advaxis's ADXS-HPV Phase 2 Results In Context
11:10 a.m. Feb. 16, 2014
- Seeking Alpha
San Fran Biotech Week Aftermath: Advaxis Is Primed To Take Off
12:59 p.m. Feb. 6, 2014
- Seeking Alpha
Inovio IL-33 Results Provide Further Validation Of Platform
12:19 p.m. Feb. 3, 2014
- Seeking Alpha
Two Deals In Two Months: Great Achievement For Advaxis
2:01 p.m. Jan. 30, 2014
- Seeking Alpha
10-K: ADVAXIS, INC.
6:00 p.m. Jan. 29, 2014
- Edgar Online - (EDG = 10Q, 10K)
Advaxis And Inovio Race For First Cervical Cancer Immunotherapy
10:05 a.m. Jan. 23, 2014
- Seeking Alpha
Covidien Completes Confluent Surgical Sale - Analyst Blog
5:00 p.m. Jan. 21, 2014
- Zacks.com
Advaxis Doses First Patient in Phase 1/2 Head and Neck Cancer Study
7:36 a.m. Jan. 21, 2014
- benzinga.com
Wright Medical Rises on OrthoRecon Sale - Analyst Blog
3:50 p.m. Jan. 17, 2014
- Zacks.com
Generic Unit at Perrigo Looks Promising - Analyst Blog
12:30 p.m. Jan. 17, 2014
- Zacks.com
ZELTIQ (ZLTQ) Worth Watching: Stock Soars 19.9% - Tale of the Tape
10:25 a.m. Jan. 17, 2014
- Zacks.com
Agios Pharmaceuticals (AGIO) Surges: Stock Moves 18.6% Higher - Tale of the Tape
10:21 a.m. Jan. 16, 2014
- Zacks.com
St. Jude Announces Promising Guidance - Analyst Blog
4:00 p.m. Jan. 15, 2014
- Zacks.com
BAX Recalls Parenteral Nutrition Injections - Analyst Blog
8:15 p.m. Jan. 6, 2014
- Zacks.com
Japan Patent Office Issues Advaxis a Notice of Allowance for Two Patent Applications Covering Its Cancer Immunotherapy Platform Technology
7:31 a.m. April 14, 2014
- GlobeNewswire
Pending Applications, Closed Public Offering, Joint Venture Formation, Executive Appointment, and Commercial Launch - Analyst Notes on Gilead, Enzymotec, Intrexon, Advaxis, and Repligen
8:00 a.m. April 1, 2014
- PR Newswire - PRF
Advaxis Receives Notice of Allowance From U.S. Patent and Trademark Office for Three Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy Platform Technology
7:30 a.m. April 1, 2014
- GlobeNewswire
Advaxis Announces Closing of Public Offering of Common Stock
4:37 p.m. March 31, 2014
- GlobeNewswire
Moskowitz: Advaxis Balance Sheet Shored Up
9:40 a.m. March 31, 2014
- ACCESSWIRE
Advaxis Announces Full Exercise of Underwriters' Over-Allotment Option
3:00 p.m. March 28, 2014
- GlobeNewswire
Team Nation Holdings Corp Officially Changes its Name; Petr Shares Rise on Brazil Outlook Upgrade
12:37 a.m. March 28, 2014
- ACCESSWIRE
Advaxis Announces Pricing of Public Offering of Common Stock
8:40 p.m. March 26, 2014
- GlobeNewswire
Advaxis Announces Proposed Public Offering of Common Stock
4:08 p.m. March 26, 2014
- GlobeNewswire
Advaxis, Inc. [ADXS] to Ring The NASDAQ Stock Market Closing Bell
12:10 p.m. March 26, 2014
- GlobeNewswire
Advaxis to Ring The NASDAQ Stock Market Closing Bell
7:30 a.m. March 26, 2014
- GlobeNewswire
Advaxis Appoints Sara Bonstein as Chief Financial Officer, Senior Vice President
5:16 p.m. March 24, 2014
- GlobeNewswire
Advaxis, Inc. "A Win-Win in Pet Therapeutics"
9:21 a.m. March 21, 2014
- ACCESSWIRE
Advaxis Discusses Global Licensing Agreement for Pet Therapeutics on Conference Call
12:45 p.m. March 20, 2014
- GlobeNewswire
Aratana and Advaxis Enter Exclusive Global Licensing Agreement
8:01 p.m. March 19, 2014
- PR Newswire - PRF
Advaxis Receives Patent in Japan for ADXS-HPV for the Treatment of Cervical Cancer
7:30 a.m. March 18, 2014
- GlobeNewswire
Advaxis and UC San Francisco to Evaluate Cancer Immunotherapy Constructs in Prostate Cancer
7:40 a.m. March 17, 2014
- GlobeNewswire
Advaxis to Present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum
9:01 a.m. March 13, 2014
- GlobeNewswire
Advaxis, Inc. "Advaxis' Immunotherapy and the Tumor Microenvironment"
3:23 p.m. March 5, 2014
- ACCESSWIRE
Advaxis Cancer Immunotherapy Featured on CNN
7:30 a.m. March 3, 2014
- GlobeNewswire
UPDATE: Advaxis Reports Japanese Patent Officer Has Granted Notice of Allowance for Two Patent Apps Covering Cancer Immunotherapy Platform Technology
6:39 a.m. April 14, 2014
- benzinga.com
UPDATE: Advaxis Receives Notice of Allowance From U.S. Patent and Trademark Office for Three Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy Platform Technology
6:33 a.m. April 1, 2014
- benzinga.com
Advaxis Announces Closing of Public Offering of Common Stock, Collects $14.07M in Gross Proceeds
3:32 p.m. March 31, 2014
- benzinga.com
But we really believe our stock is worth $4
7:19 a.m. March 27, 2014
- Seeking Alpha
UPDATE: Advaxis Announces Proposed Public Offering of Common Stock
3:10 p.m. March 26, 2014
- benzinga.com
Advaxis Receives Patent in Japan for ADXS-HPV for the Treatment of Cervical Cancer
6:31 a.m. March 18, 2014
- benzinga.com
Advaxis's ADXS-HPV Phase 2 Results In Context
11:10 a.m. Feb. 16, 2014
- Seeking Alpha
San Fran Biotech Week Aftermath: Advaxis Is Primed To Take Off
12:59 p.m. Feb. 6, 2014
- Seeking Alpha
Inovio IL-33 Results Provide Further Validation Of Platform
12:19 p.m. Feb. 3, 2014
- Seeking Alpha
Two Deals In Two Months: Great Achievement For Advaxis
2:01 p.m. Jan. 30, 2014
- Seeking Alpha
10-K: ADVAXIS, INC.
6:00 p.m. Jan. 29, 2014
- Edgar Online - (EDG = 10Q, 10K)
Advaxis And Inovio Race For First Cervical Cancer Immunotherapy
10:05 a.m. Jan. 23, 2014
- Seeking Alpha
Covidien Completes Confluent Surgical Sale - Analyst Blog
5:00 p.m. Jan. 21, 2014
- Zacks.com
Advaxis Doses First Patient in Phase 1/2 Head and Neck Cancer Study
7:36 a.m. Jan. 21, 2014
- benzinga.com
Wright Medical Rises on OrthoRecon Sale - Analyst Blog
3:50 p.m. Jan. 17, 2014
- Zacks.com
Generic Unit at Perrigo Looks Promising - Analyst Blog
12:30 p.m. Jan. 17, 2014
- Zacks.com
ZELTIQ (ZLTQ) Worth Watching: Stock Soars 19.9% - Tale of the Tape
10:25 a.m. Jan. 17, 2014
- Zacks.com
Agios Pharmaceuticals (AGIO) Surges: Stock Moves 18.6% Higher - Tale of the Tape
10:21 a.m. Jan. 16, 2014
- Zacks.com
St. Jude Announces Promising Guidance - Analyst Blog
4:00 p.m. Jan. 15, 2014
- Zacks.com
BAX Recalls Parenteral Nutrition Injections - Analyst Blog
8:15 p.m. Jan. 6, 2014
- Zacks.com
Japan Patent Office Issues Advaxis a Notice of Allowance for Two Patent Applications Covering Its Cancer Immunotherapy Platform Technology
7:31 a.m. April 14, 2014
- GlobeNewswire
Pending Applications, Closed Public Offering, Joint Venture Formation, Executive Appointment, and Commercial Launch - Analyst Notes on Gilead, Enzymotec, Intrexon, Advaxis, and Repligen
8:00 a.m. April 1, 2014
- PR Newswire - PRF
Advaxis Receives Notice of Allowance From U.S. Patent and Trademark Office for Three Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy Platform Technology
7:30 a.m. April 1, 2014
- GlobeNewswire
Advaxis Announces Closing of Public Offering of Common Stock
4:37 p.m. March 31, 2014
- GlobeNewswire
Moskowitz: Advaxis Balance Sheet Shored Up
9:40 a.m. March 31, 2014
- ACCESSWIRE
Advaxis Announces Full Exercise of Underwriters' Over-Allotment Option
3:00 p.m. March 28, 2014
- GlobeNewswire
Team Nation Holdings Corp Officially Changes its Name; Petr Shares Rise on Brazil Outlook Upgrade
12:37 a.m. March 28, 2014
- ACCESSWIRE
Advaxis Announces Pricing of Public Offering of Common Stock
8:40 p.m. March 26, 2014
- GlobeNewswire
Advaxis Announces Proposed Public Offering of Common Stock
4:08 p.m. March 26, 2014
- GlobeNewswire
Advaxis, Inc. [ADXS] to Ring The NASDAQ Stock Market Closing Bell
12:10 p.m. March 26, 2014
- GlobeNewswire
Advaxis to Ring The NASDAQ Stock Market Closing Bell
7:30 a.m. March 26, 2014
- GlobeNewswire
Advaxis Appoints Sara Bonstein as Chief Financial Officer, Senior Vice President
5:16 p.m. March 24, 2014
- GlobeNewswire
Advaxis, Inc. "A Win-Win in Pet Therapeutics"
9:21 a.m. March 21, 2014
- ACCESSWIRE
Advaxis Discusses Global Licensing Agreement for Pet Therapeutics on Conference Call
12:45 p.m. March 20, 2014
- GlobeNewswire
Aratana and Advaxis Enter Exclusive Global Licensing Agreement
8:01 p.m. March 19, 2014
- PR Newswire - PRF
Advaxis Receives Patent in Japan for ADXS-HPV for the Treatment of Cervical Cancer
7:30 a.m. March 18, 2014
- GlobeNewswire
Advaxis and UC San Francisco to Evaluate Cancer Immunotherapy Constructs in Prostate Cancer
7:40 a.m. March 17, 2014
- GlobeNewswire
Advaxis to Present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum
9:01 a.m. March 13, 2014
- GlobeNewswire
Advaxis, Inc. "Advaxis' Immunotherapy and the Tumor Microenvironment"
3:23 p.m. March 5, 2014
- ACCESSWIRE
Advaxis Cancer Immunotherapy Featured on CNN
7:30 a.m. March 3, 2014
- GlobeNewswire
(0)
(0)
